Peer to Peer

Topical Corticosteroid Tachyphylaxis: Why Don’t Patients Adhere to Treatment?

In this episode of the “Peer to Peer” podcast series with Dr. Vincent DeLeo, Dr. Steven Feldman discusses results from a recent study he and his colleagues conducted on topical corticosteroids and treatment-resistant atopic dermatitis. He notes that poor use of medications can be a cause of topical corticosteroid tachyphylaxis and provides some tips on how physicians can get patients to better adhere to treatment.

Questions for Dr. Steven Feldman on tachyphylaxis and treatment adherence? Contact the Editorial Office and we'll post the answer here.


 

Recommended Reading

Tribulus terrestris
MDedge Dermatology
Artificial Intelligence for Clinical Decision Support
MDedge Dermatology
Laser tattoo removal techniques continue to be refined
MDedge Dermatology
Rivaroxaban beats aspirin for VTE
MDedge Dermatology
Syphilis surge drives USPSTF reaffirmation of early screening for all pregnant women
MDedge Dermatology
FDA approval for 2 HIV drugs
MDedge Dermatology
Red flag raised on CMS indication–based formulary design policy
MDedge Dermatology
Physician groups call for CMS to drop E/M proposal
MDedge Dermatology
Modest alcohol and NAFLD
MDedge Dermatology
September 2018 Issue Highlights
MDedge Dermatology